Peter Riskind, MD, PhD is a Professor of Clinical Neurology and is the Director of the MS Clinic at UMMHC.  He received his MD and PhD from the University of Texas and completed his neurology residency at Massachusetts General Hospital.  He was formerly the Chief of the NeuroImmunology Unit at Massachusetts General Hospital and Director of the MS Clinic at Spaulding Rehabilitation Hospital.  He specializes in Multiple Sclerosis and related neuroimmunologic disorders and is a member of the Clinical Advisory Board for the Massachusetts Chapter of the National Multiple Sclerosis Society.  He is board-certified in Neurology and Psychiatry.

The Multiple Sclerosis Clinic at UMass Memorial Health Care participates in many clinical trials to evaluate the effectiveness of a variety of drugs and treatments for MS. Currently it is the site of several different clinical trials involving patients with Relapsing Remitting and Primary Progressive MS. We are involved in trials to prevent the future worsening of MS, and to improve the quality of life of our patients.

Along with clinical trials, we are also involved in several clinical research studies which are aimed at finding the cause or causes of the MS.  These studies generally require only one clinic visit and may allow family members to participate by donating blood and filling our questionnaires.